PPARG and cancer: The MMOC allowed identification of numerous cancer chemopreventive agents such as resveratrol [25], deguelin [26], brassinin [27], sulforaphan analogs, certain vitamin D analogs ([28], and PPARγ agonists such as troglitazone, among others [29].